hipercept europe ltd
hipercept europe ltd Company Information
Company Number
07868299
Next Accounts
Aug 2025
Industry
Computer consultancy activities
Shareholders
rp newco xxvii llc
Group Structure
View All
Contact
Registered Address
c/o company secretarial departme, 280 bishopsgate, london, EC2M 4AG
Website
hipercept.comhipercept europe ltd Estimated Valuation
Pomanda estimates the enterprise value of HIPERCEPT EUROPE LTD at £0 based on a Turnover of £0 and 0.68x industry multiple (adjusted for size and gross margin).
hipercept europe ltd Estimated Valuation
Pomanda estimates the enterprise value of HIPERCEPT EUROPE LTD at £8.3k based on an EBITDA of £1.8k and a 4.72x industry multiple (adjusted for size and gross margin).
hipercept europe ltd Estimated Valuation
Pomanda estimates the enterprise value of HIPERCEPT EUROPE LTD at £0 based on Net Assets of £-587.7k and 2.29x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Hipercept Europe Ltd Overview
Hipercept Europe Ltd is a live company located in london, EC2M 4AG with a Companies House number of 07868299. It operates in the information technology consultancy activities sector, SIC Code 62020. Founded in December 2011, it's largest shareholder is rp newco xxvii llc with a 100% stake. Hipercept Europe Ltd is a established, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Hipercept Europe Ltd Health Check
There is insufficient data available to calculate a health check for Hipercept Europe Ltd. Company Health Check FAQs
0 Strong
0 Regular
2 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Hipercept Europe Ltd
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Hipercept Europe Ltd
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- Hipercept Europe Ltd
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Hipercept Europe Ltd
- - Industry AVG
Employees
There is insufficient data available for this Key Performance Indicator!
- - Hipercept Europe Ltd
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Hipercept Europe Ltd
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Hipercept Europe Ltd
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Hipercept Europe Ltd
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Hipercept Europe Ltd
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Hipercept Europe Ltd
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (18 weeks)
- - Hipercept Europe Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 19983.3%, this is a higher level of debt than the average (57.7%)
- - Hipercept Europe Ltd
- - Industry AVG
HIPERCEPT EUROPE LTD financials
Hipercept Europe Ltd's latest turnover from November 2023 is estimated at 0 and the company has net assets of -£587.7 thousand. According to their latest financial statements, we estimate that Hipercept Europe Ltd has no employees and maintains cash reserves of £3 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Nov 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | May 2015 | May 2014 | May 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||
| Other Income Or Grants | |||||||||||
| Cost Of Sales | |||||||||||
| Gross Profit | |||||||||||
| Admin Expenses | |||||||||||
| Operating Profit | |||||||||||
| Interest Payable | |||||||||||
| Interest Receivable | |||||||||||
| Pre-Tax Profit | |||||||||||
| Tax | 0 | ||||||||||
| Profit After Tax | 0 | ||||||||||
| Dividends Paid | 0 | ||||||||||
| Retained Profit | 0 | ||||||||||
| Employee Costs | |||||||||||
| Number Of Employees | 2 | 2 | 2 | 3 | 3 | 4 | 4 | ||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Nov 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | May 2015 | May 2014 | May 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 1,715 | 1,715 | 2,287 | 2,504 | 2,273 | 2,515 | 2,810 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 1,715 | 1,715 | 2,287 | 2,504 | 2,273 | 2,515 | 2,810 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 6,711 | 112,004 | 14,750 | 13,700 | 125,364 | 94,004 | 19,335 | 142,618 | 187,442 | 215,921 |
| Group Debtors | 0 | 1,334 | 0 | 0 | 0 | 0 | 0 | 68,198 | 0 | 0 | 0 |
| Misc Debtors | 0 | 142 | 2,477 | 151,433 | 5,338 | 10,822 | 3,446 | 5,397 | 0 | 0 | 0 |
| Cash | 2,956 | 6,834 | 13,493 | 43,535 | 75,884 | 30,759 | 17,138 | 18,807 | 66,648 | 52,432 | 66,457 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 2,956 | 15,021 | 127,974 | 209,718 | 94,922 | 166,945 | 114,588 | 111,737 | 209,266 | 239,874 | 282,378 |
| total assets | 2,956 | 15,021 | 127,974 | 209,718 | 96,637 | 168,660 | 116,875 | 114,241 | 211,539 | 242,389 | 285,188 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 10,492 | 36,979 | 32,463 | 35,726 | 26,691 | 21,469 | 12,498 | 70,193 | 86,578 | 130,475 |
| Group/Directors Accounts | 580,201 | 566,622 | 359,484 | 258,135 | 26,202 | 29,253 | 18,244 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 10,504 | 27,164 | 27,685 | 12,882 | 3,962 | 5,691 | 7,167 | 14,890 | 0 | 0 | 0 |
| total current liabilities | 590,705 | 604,278 | 424,148 | 303,480 | 65,890 | 61,635 | 46,880 | 27,388 | 70,193 | 86,578 | 130,475 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 646 | 646 | 646 | 646 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 646 | 646 | 646 | 646 |
| total liabilities | 590,705 | 604,278 | 424,148 | 303,480 | 65,890 | 61,635 | 46,880 | 28,034 | 70,839 | 87,224 | 131,121 |
| net assets | -587,749 | -589,257 | -296,174 | -93,762 | 30,747 | 107,025 | 69,995 | 86,207 | 140,700 | 155,165 | 154,067 |
| total shareholders funds | -587,749 | -589,257 | -296,174 | -93,762 | 30,747 | 107,025 | 69,995 | 86,207 | 140,700 | 155,165 | 154,067 |
| Nov 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | May 2015 | May 2014 | May 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||
| Operating Profit | |||||||||||
| Depreciation | 0 | 0 | 0 | 1,715 | 0 | 572 | 734 | 706 | 759 | 840 | 1,687 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | ||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -8,187 | -106,294 | -51,702 | 147,145 | -117,148 | 38,736 | 4,520 | -49,688 | -44,824 | -28,479 | 215,921 |
| Creditors | -10,492 | -26,487 | 4,516 | -3,263 | 9,035 | 5,222 | 8,971 | -57,695 | -16,385 | -43,897 | 130,475 |
| Accruals and Deferred Income | -16,660 | -521 | 14,803 | 8,920 | -1,729 | -1,476 | -7,723 | 14,890 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | -646 | 0 | 0 | 0 | 646 |
| Cash flow from operations | |||||||||||
| Investing Activities | |||||||||||
| capital expenditure | 0 | ||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | 0 | ||||||||||
| Financing Activities | |||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 13,579 | 207,138 | 101,349 | 231,933 | -3,051 | 11,009 | 18,244 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||
| interest | |||||||||||
| cash flow from financing | |||||||||||
| cash and cash equivalents | |||||||||||
| cash | -3,878 | -6,659 | -30,042 | -32,349 | 45,125 | 13,621 | -1,669 | -47,841 | 14,216 | -14,025 | 66,457 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -3,878 | -6,659 | -30,042 | -32,349 | 45,125 | 13,621 | -1,669 | -47,841 | 14,216 | -14,025 | 66,457 |
hipercept europe ltd Credit Report and Business Information
Hipercept Europe Ltd Competitor Analysis
Perform a competitor analysis for hipercept europe ltd by selecting its closest rivals, whether from the INFORMATION AND COMMUNICATION sector, other established companies, companies in EC2M area or any other competitors across 12 key performance metrics.
hipercept europe ltd Ownership
HIPERCEPT EUROPE LTD group structure
Hipercept Europe Ltd has no subsidiary companies.
Ultimate parent company
RP NEWCO XXVIII LLC
#0132614
1 parent
HIPERCEPT EUROPE LTD
07868299
hipercept europe ltd directors
Hipercept Europe Ltd currently has 5 directors. The longest serving directors include Mr William Chaney (Jul 2019) and Ms Ashley Glover (Jul 2019).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr William Chaney | United States | 54 years | Jul 2019 | - | Director |
| Ms Ashley Glover | United States | 53 years | Jul 2019 | - | Director |
| Mr Michael Britti | United States | 65 years | Jan 2020 | - | Director |
| Mr Vinit Doshi | United States | 47 years | Jan 2022 | - | Director |
| Mr Mark Falkenberg | United States | 68 years | Aug 2022 | - | Director |
P&L
November 2023turnover
0
-100%
operating profit
1.8k
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
November 2023net assets
-587.7k
0%
total assets
3k
-0.8%
cash
3k
-0.57%
net assets
Total assets minus all liabilities
hipercept europe ltd company details
company number
07868299
Type
Private limited with Share Capital
industry
62020 - Computer consultancy activities
incorporation date
December 2011
age
14
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
November 2023
previous names
N/A
accountant
-
auditor
RICKARD LUCKIN LIMITED
address
c/o company secretarial departme, 280 bishopsgate, london, EC2M 4AG
Bank
-
Legal Advisor
-
hipercept europe ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to hipercept europe ltd.
hipercept europe ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for HIPERCEPT EUROPE LTD. This can take several minutes, an email will notify you when this has completed.
hipercept europe ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
